UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: October 15, 2024
Accession Number: 0001193125-24-234378
Submission Type: POS AM
CIK: 0001498382
Company Name: Kintara Therapeutics, Inc.
File Number: 333-279368